FTC cracks down on 10 drugmakers

The latest stories trending on MedCity News.

Editor's Pick

Top Story FTC Sees Red Over Alleged Misuse of FDA Orange Book, Puts 10 Pharmas on Notice The Federal Trade Commission says more than 100 patents from 10 biopharma companies are improperly listed in the FDA's official publication of approved products. Such listings delay generic competition, which reduces consumer choice and keeps prices high, the regulator said. Sponsored Content Biotech Showcase, January 8–10, 2024 Presented by EBD Group Join our premier investor conference in San Francisco, empowering private & micro-mid-cap biotech companies to showcase innovations & engage one-on-one with investors. Save $400 by Nov. 10th. Learn More! Sponsored Content Heard at HLTH 2023: Marley Medical Presented by Marley Medical CEO Chris Hogg on how Marley Medical stands out from competitors. Watch Now

Featured News

Covera Health Acquires CoRead, Secures up to $50M To Improve Radiology Covera Health has finalized its acquisition of CoRead, the companies announced last week but did not disclose the terms of the deal. Covera also announced that it raised up to $50 million in additional Series C funding led by Insight Partners. Breaking the Mold: Why Non-Linear Career Paths Create Leaders of the Future Perhaps more of us would find greater joy and fulfillment at work, if we embraced the idea of being a beginner and starting anew. The most fulfilling path in the 21st century isn't necessarily a straight line. Baylor Medicine Joins Other Health Systems in Shifting Physical Therapy to the Home Baylor Medicine teamed up with Luna to launch a program expanding access to in-home physical therapy for patients in the Houston area. Luna, a provider of in-home physical therapy, has similar partnerships with more than two dozen health systems. These partnerships help health systems expand access to care and increase their geographic coverage across their markets, said Palak Shah, Luna's co-founder. CMS Proposed Rule Tamps Down On MA Predatory Marketing CMS proposed a new rule that would set a flat amount — $632 — that MA plans can pay agents and brokers when they help enroll a person into any MA plan. The proposed rule also addresses behavioral health access and prior authorization. Ventyx Drops Drug for Psoriasis as Data Look Uncompetitive in Tight TYK2 Field Ventyx Biosciences is stopping work on its lead drug candidate in plaque psoriasis and psoriatic arthritis. Despite achieving the goals of its Phase 2 test in psoriasis, the results are short of those achieved by big pharmaceutical companies with molecules that address the same target. I Used AI Tech To Find My Own Cancer Clinical Trial, and You Can Too My phone chimed with a notification, signaling the availability of a new CT test result […]

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Jeff Smith, CEO of Bamboo Health For October's guest interview, we are joined by Jeff Smith, who became the CEO of digital health company Bamboo Health this month. Before Bamboo, Smith held several leadership positions at Lumeris, a value-based care managed services operator for health systems. Before that, he spent more than six years in leadership roles at CVS. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe